Vulcan Biologics

About:

Vulcan Biologics provides a biotechnology platform that offers stable and persistent modulation of microbiomes.

Website: https://vulcanbiologics.com/

Top Investors: National Science Foundation

Description:

Vulcan Biologics provides a biotechnology platform that offers stable and persistent modulation of the microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiome. Its platform uses bacteriophages that alter the gut bacterias of the microbiome that helps in the treatment of gluten-related disorders like gluten sensitivity and celiac disease. Vulcan Biologics was founded in 2019 and is headquartered in Irvine, California.

Total Funding Amount:

$990000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)vulcanbiologics.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-12-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai